I’m 65, and though I’ve been able to stave off the worst of what normally passes for the “aging process”—as can almost anyone by paying attention to how you eat, sleep, train, move, and live—the fact remains that I’m not training like I used to. It’s not so much that I’m “losing” a step, although… Read More: Mid-60s Check-in: 5 Ways My Workout Has Changed »
Pannus is an abnormal growth of tissue that develops in the joints. It can form in the later stages of rheumatoid arthritis. Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation in the joints. When a person has RA, the synovium, which is the protective lining of the joints, grows much thicker, resulting in… Read More: What is the link between pannus and rheumatoid arthritis? »
U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday’s approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter’s flu season. Xofluza is a pill that can reduce severity and shorten duration of flu symptoms after one just dose. It was… Read More: US approves new type of flu drug »
FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute Uncomplicated Influenza Print this page October 24, 2018 — Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48… Read More: FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute… »